A prospective evaluation of pharmacy contributions to post-take ward rounds

Pharmaceutical Journal

Volumn 270, Issue 7256, 2003, Pages 22-23

  Bednall, Ruth ^a   McRobbie, Duncan ^b   Russell, Sarah Jane ^b   West, Tony ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PHARMACY; EVALUATION; HEALTH CARE FINANCING; HUMAN; PHARMACEUTICAL CARE; PHARMACIST; PROSPECTIVE STUDY; TIME; WARD;

EID: 0038487411     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD. Servi D, et al. Incidence of adverse drug events and potential adverse events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34.
2. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health-Syst Pharm 1997;54:1591-5.
3. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
4. Lesar TS, Briceland LL, Delcoure K, Parmalee JC, Masta-Gornic V, Pohl H. Medication prescribing errors in a teaching hospital. JAMA 1990;263:2329-34.
5. Hocking G, Kalyanaraman R, deMello WF. Better drug history taking: an assessment of the DRUGS mnemonic. J R Soc Med 1998;91:305-6.
6. Advisory Board, Clinical Initiatives Centre. Reducing adverse drug events. Best practices in reporting and prescribing. Washington DC: CIC; 2000.